US 7,540,382 B2
	Stabilized liquid protein formulations in pharmaceutical containers
Fabrizio Samaritani, Rome (Italy); and Alessandra Del Rio, Rome (Italy)
Assigned to Ares Trading S.A., Aubonne (Switzerland)
Appl. No. 10/556,467 PCT Filed May 12, 2004, PCT No. PCT/EP2004/050779 § 371(c)(1), (2), (4) Date Nov. 16, 2006, PCT Pub. No. WO2004/100979, PCT Pub. Date Nov. 25, 2004.
Claims priority of application No. 03010671 (EP), filed on May 13, 2003.
Prior Publication US 2007/0092487 A1, Apr. 26, 2007
Int. Cl. B65D 1/09 (2006.01); B65D 83/04 (2006.01); B65D 85/42 (2006.01); A61K 38/21 (2006.01); C08F 14/18 (2006.01); C08F 114/18 (2006.01); C08F 214/18 (2006.01)

U.S. Cl. 206—528  [424/85.6; 526/255]

12 Claims

1. A method for containing a composition comprising providing a liquid pharmaceutical composition ready for injection and comprising an interferon β as an active ingredient into a container which is a vial, an ampoule, a small bottle or a tube with a closure stopper wherein the closure stopper is coated with polytetrafluoruethylene (PTFE).